Future Medical Device Companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Future Medical Device Companies

STXS 2.910

-0.3%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (80)	10/5/2007 11:21:08 AM
From: semi_infinite	Read Replies (1) of 136

I just watched the video replay on CNBC. He did acknowledge that he has competition in the electrophysiology space, which would be STXS. What he referred to as "no competition" is the structural heart disease space done through blood vessel access. I would agree with that narrow definition. ISRG does structural heart repairs but access is from outside of the blood vessels and heart. Corindus is also doing robotics work through blood vessels but they may be not be targeting structural heart disease at first. Washington U. in DC is heading the clinical tests there. STXS may and Corindus will target structural heart disease in the future I expect. There is no barrier to entry for them.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next